Your Impact
Where the Money Goes

Researchers in the Berger Lab at Fred Hutch.

You power cures

Obliteride fuels the fearless science that will change the world

We need fearless science now more than ever. That’s where you come in. Your Obliteride dollars support research to help stop cancer and infectious diseases and save lives. Thanks to our generous sponsors, 100% of participant-raised dollars fuel Hutch scientists working on the frontlines to create a healthier world for everyone.

Meet some of the researchers you support

Because of the urgent threat of COVID-19, particularly for people affected by cancer, 50% of the funds Obliteriders raised in 2020 are supporting critical coronavirus research at Fred Hutch and 50% support our core goal: curing cancer faster. In 2021, all participant-raised dollars will fuel cancer research. Meet some of the passionate researchers Obliteride supports:

Dr. Melody Campbell

Bringing cells to light

Dr. Campbell is the scientific director of the Hutch's electron microscopy center. Her lab studies how cells communicate with their surroundings, increasing our understanding of the mechanisms that keep them healthy or go awry in cancer and other diseases. She is also a leader in the field of cyro-EM, a technique that allows scientists to use powerful microscopes to see how cells work and grow, and to detect minute changes in their fundamental building blocks — information that can help improve cancer treatments.

Dr. Elizabeth “Betz” Halloran

THE POLICY LEADER

Dr. Betz Halloran is a global expert in using statistics and dynamic models to understand infectious disease outbreaks and to evaluate vaccines and vaccination strategies. Her work is used to develop strategies to stop outbreaks of global threats such as Zika virus disease, Ebola virus disease, influenza, cholera and dengue fever.

Dr. Rachel Issaka

INCREASING ACCESS TO SAVE LIVES

As a gastroenterologist and clinical researcher, Dr. Issaka is working to decrease the number of people who die from colorectal cancer, especially in communities that have unjust and unequal access to medical care. “Screening is a way to not only prevent disease but reduce racial and economic disparities,” says Dr. Issaka. “We need to close that gap so that every citizen can benefit from … advances in cancer care and prevention.” Because colorectal cancer is one of the fastest-rising cancers in the U.S. — and because early detection can improve outcomes — Dr. Issaka’s work has the potential to save countless lives.

Dr. Steve Pergam

Protecting our communities

Dr. Pergam is an infectious disease researcher at Fred Hutch and medical director of infection prevention at Seattle Cancer Care Alliance (SCCA). Since the first days of the pandemic, Dr. Pergam has applied his expertise, clarity, and compassion to lead the infection control and response strategy at SCCA and Fred Hutch. Dubbed the “Miss Manners of Social Distancing” by The Seattle Times, he has also provided critical support to policymakers and the general public — helping to protect patients, caregivers, and our communities.